Nearly 90 percent of U.S. gastroenterologists are open to leveraging artificial intelligence to improve colonoscopies, according to a study published in Endoscopy International Open.
Independent gastroenterology practice Charleston (S.C.) GI opened an endoscopy center in Summerville, S.C.
Takeda has entered into a $1.04 billion licensing agreement with Arrowhead Pharmaceuticals around its phase 2 therapy ARO-AAT, which was designed to treat alpha-1 antitrypsin-associated liver disease.
The University of Minnesota in Minneapolis launched a new clinical trial that will use CRISPR genetic engineering to treat metastatic gastrointestinal solid tumor cancer.
Nearly 1 in 12 colonoscopies without an associated intervention ended with an out-of-network claim, according to a new study published in the Annals of Internal Medicine.
Middletown, Conn.-based Middlesex Health recently opened its Center for Digestive Health to unite all its gastrointestinal services.
More articles on surgery centers:
Colonoscopy screening numbers starting to rebound — 10 GI industry key notes
5 most-read stories in GI this week — Gastro Health 1st to use endoscopic gastroscope in US
Florida Digestive Health Specialists expands presence
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
